Based on the information available, I cannot provide an exact timeframe for accessing Vascepa Aid. However, I can provide some context about Vascepa and its manufacturer's patient assistance program.

Vascepa (generic name: icosapent ethyl) is a prescription medication approved by the FDA to lower triglyceride levels in adult patients. It is manufactured by Amarin Pharma, Inc.

Amarin Pharma offers a patient assistance program called Vascepa Aid, which provides Vascepa at no cost to eligible patients who cannot afford their medication. The program is designed to help patients with a household income at or below 500% of the federal poverty level, or those who are experiencing temporary financial hardship.

To apply for Vascepa Aid, patients can visit the program's website and follow the instructions for submitting an application. The application process typically involves providing proof of income, insurance information, and a prescription from a healthcare provider.

It is important to note that the processing time for patient assistance programs can vary depending on several factors, such as the volume of applications received and the complexity of the case. Therefore, it is difficult to provide an exact timeframe for accessing Vascepa Aid.

In summary, while I cannot provide a specific timeframe for accessing Vascepa Aid, I can confirm that Amarin Pharma offers a patient assistance program for eligible patients who cannot afford Vascepa. Patients can apply for the program through the Vascepa Aid website.

Sources:

* [Vascepa Aid](https://www.vascepaaid.com/)
* [Vascepa (icosapent ethyl) capsules](https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202921s023lbl.pdf)
* [DrugPatentWatch: Vascepa](https://www.drugpatentwatch.com/drugs/vascepa)